BioMarin Pharmaceutical Inc

Write a Review415-506-6700

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio is comprised of three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme for mucopolysaccharidosis VI, a product wholly developed and commercialized by BioMarin, Aldurazyme for mucopolysaccharidosis I and Orapred prednisolone sodium phosphate oral, a solution for inflammatory conditions. The company is located in Novato, Calif.